| (1) |
Burrow GN. 1993 Thyroid function and hyperfunction
during gestation, Endocr Rev. 14: 194-202. |
| (2) |
Daniels GH. 1995 Thyroid disease in pregnancy:
a clinical review. Endocr Pract. 1: 287-301. |
| (3) |
Roti E, Minelli R, Salvi M. 1996 Clinical review
80: management of hyperthyroidism and hypothyroidism in the pregnant woman.
J Clin Endocrinol Metab. 81: 1679-1682. |
| (4) |
Inzucchi SE, Burrow GN. 1997 Hyperthyroidism
in pregnancy. Curr Ther Endocrinol Metab. 6: 312-317. |
| (5) |
Mestman JH. 1998 Hyperthyroidism in pregnancy.
Endocrinol Metab Clin North Am. 27: 127-149. |
| (6) |
Masiukiewicz US, Burrow GN. 1999 Hyperthyroidism
in pregnancy: diagnosis and treatment. Thyroid. 9: 647-652. |
| (7) |
Davis LE. Lucas MJ, Hankins GD. Roark ML. Cunningham
FG. 1989 Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol.
160: 63-70. |
| (8) |
Millar LK, Wing DA, Leung AS, Koonings PP. Montoro
MN, Mestman JH. 1994 Low birth weight and preeclampsia in pregnancies
complicated by hyperthyroidism. Obstet Gynecol. 84: 946-949. |
| (9) |
Mitsuda N, Tamaki H, Amino N, Hosono T, Miyai K,
Tanizawa O. 1992 Risk factors for developmental disorders in infants
born to women with Graves disease. Obstet Gynecol. 80: 359-364. |
| (10) |
Easterling TR. Schmucker BC, Carlson KL, Millard
SP, Benedetti TJ. 1991 Maternal hemodynamics in pregnancies complicated
by hyperthyroidism. Obstet Gynecol. 78: 348-352. |
| (11) |
Momotani N, Ito K, Hamada N. Ban Y. Nishikawa Y,
Mimura T. 1984 Maternal hyperthyroidism and congenital malformation
in the offspring. Clin Endocrinol(Oxf). 20: 695-700. |
| (12) |
Wing DA. Millar LK. Koonings PP. Montoro MN, Mestman
JH. 1994 A comparison of propylthiouracil versus methimazole in the
treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol. 170: 90-95. |
| (13) |
Momotani N, Noh J. Oyanagi H, Ishikawa N. Ito K.
1986 Antithyroid drug therapy for Graves' disease during pregnancy, Optimal
regimen for fetal thyroid status, N Engl J Med. 315: 24-28. |
| (14) |
Wang R, Nelson JC, Weiss RM, Wilcox RB. 2000
Accuracy of free thyroxine measurements across natural ranges of thyroxine
binding to serum proteins. Thyroid. 10: 31-39. |
| (15) |
Momotani N, Noh JY, Ishikawa N, Ito K. 1997 Effects
of propylthiouracil and methimazole on fetal thyroid status in mothers with
Graves' hyperthyroidism. J Clin Endocrinol Metab. 82: 3633-3636. |
| (16) |
Marchant B, Brownlie BE, Hart DM. Horton PW, Alexander
WD. 1977 The placental transfer of propylthiouracil, methimazole, and
carbimazole. J Clin Endocrinol Metab. 45: 1187-1193. |
| (17) |
Mortimer RH. Cannell GR, Addison RS. Johnson LP,
Roberts MS. Bemus l. 1997 Methimazole and propylthiouracil equally cross
the perfused human term placental lobule, J Clin Endocrinol Metab. 82: 3099
-102. |
| (18) |
Gardner DF. Cruikshank DP, Hays PM, Cooper DS.
1986 Pharmacology of propylthiouracil(PTU) in pregnant hyperthyroid women:
correlation of maternal PTU concentrations with cord serum thyroid function
tests. J Clin Endocrinol Metab. 62: 217-220. |
| (19) |
Stephan MJ, Smith DW, Ponzi JW, Alden ER. 1982
Origin of scalp vertex aplasia cutis. J Pediatr. 101: 850-853. |
| (20) |
Van Dijke CP, Heydendael RJ, De Kleine MJ. 1987
Methimazole, carbimazole, and congenital skin defects. Ann Intern Med. 106:
60-61. |
| (21) |
Milham S. Elledge W. 1972 Maternal methimazole
and congenital defects in children, Teratology. 5: 125-126. |
| (22) |
Mujtaba Q. Burrow GN. 1975 Treatment of hyperthyroidism
in pregnancy with propylthiouracil and methimazole. Obstet Gynecol. 46:
282-286. |
| (23) |
Kalb RE, Grossman ME. 1986 The association of
aplasia cutis congenita with therapy of maternal thyroid disease. Pediatr
Dermatol. 3: 327-330. |
| (24) |
Farine D. Maidman J. Rubin S. Chao S. 1988 Elevated
a-fetoprotein in pregnancy complicated by aplasia cutis after exposure to
methimazole, Obstet Gynecol. 71: 996-997. |
| (25) |
Dutertre JP, Jonville AP, Moraine C, Autret E.
1991 Aplasia cutis after exposure to carbimazole in utero. J Gynecol Obstet
Biol Reprod(Paris), 20: 575-576. |
| (26) |
Mandel SJ, Brent GA. Larsen PR. 1994 Review of
antithyroid drug use during pregnancy and report of a case of aplasia cutis.
Thyroid. 4: 129 -133. |
| (27) |
Vogt T, Stolz W, Landthaler M. 1995 Aplasia cutis
congenita after exposure to methimazole: a causal relationship? Br J Dermatol.
133: 994-996. |
| (28) |
Diez-Delgado Rubio J, Belmonte Martin MJ, Calvo Bonachera
MD, Lopez Candel E. 1999 Aplasia cutis as a teratogenic effect of methimazole.
An Esp Pediatr. 51: 290-292. |
| (29) |
Martinez-Frias ML, Cereijo A, Rodriguez-Pinilla E,
Urioste M. 1992 Methimazole in animal feed and congenital aplasia cutis.
Lancet. 339: 742-743. |
| (30) |
Clementi M, Di Gianantonio E, Pelo E, Mammi I, Basile
RT, Tenconi R. 1999 Methimazole embryopathy: delineation of the phenotype.
Am J Med Genet. 83: 43-46. |
| (31) |
Johnsson E, Larsson G, Ljunggren M. 1997 Severe
malformations in infant born to hyperthyroid woman on methimazole. Lancet.
350: 1520. |
| (32) |
Cooper DS. 1985 Propylthiouracil levels in hyperthyroid
patients unresponsive to large doses. Evidence of poor patient compliance.
Ann Intem Med. 102: 328 -331. |
| (33) |
Sitar DS, Abu-Bakare A. Gardiner RJ. 1982 Propylthiouracil disposition
in pregnant and post-partum women. Pharmacology. 25: 57-60. |
| (34) |
Sato K, Mimura H, Kato S, Isozaki O, Tsushima T,
Shizume K. 1983 Serum propylthiouracil concentration in patients with
Graves' disease with various clinical course. Acta Endocrinol(Copenh). 104:
189-194. |
| (35) |
Skellern GG, Knight BI, Otter M, Low CK, Alexander WD. 1980 The
pharmacokinetics of methimazole in pregnant patients after oral administration
of carbimazole, Br J Clin Pharmacol. 9: 145-147. |
| (36) |
Hamburger JI. 1992 Diagnosis and management of
Graves' disease in pregnancy. Thyroid. 2: 219-224. |
| (37) |
Ibbertson HK, Seddon RJ, Croxson MS. 1975 Fetal hypothyroidism
complicating medical treatment of thyrotoxicosis in pregnancy. Clin Endocrinol(Oxf).
4: 521-523. |
| (38) |
Ochoa-Maya MR, Frates MC, Lee-Parritz A, Seely EW.
1999 Resolution of fetal goiter after discontinuation of propylthiouracil
in a pregnant woman with Graves' hyperthyroidism. Thyroid. 9: 1111-1114. |
| (39) |
Friedland DR, Rothschild MA. 2000 Rapid resolution of fetal goiter
associated with maternal Grave's(sic) disease: a case report. J Pediatr
Otorhinolaryngol. 54: 59-62. |
| (40) |
Cheron RG, Kaplan MM, Larsen PR, Selenkow HA, Crigler
Jr JF. 1981 Neonatal thyroid function after propylthiouracil therapy
for maternal Graves' disease. N Engl J Med. 304: 525-528. |
| (41) |
Mortimer RH, Tyack SA, Galligan JP, Perry-Keene DA, Tan YM. 1990
Graves' disease in pregnancy: TSH receptor binding inhibiting immunoglobulins
and maternal and neoriatal thyroid function. Clin Endocrinol(Oxf). 32: 141-152. |
| (42) |
Haddow JE, Palpmaki GE, Allan WC, et al. 1999
Maternal thyroid deficiency during pregnancy and subsequent neuropsychological
development of the child, N Engl J Med. 341: 549-555. |
| (43) |
Messer PM, Hauffa BP, Olbricht T, Benker G, Kotulla P, Reinwein D.
1990 Antithyroid drug treatment of Graves' disease in pregnancy: Iong-term
effects on somatic growth, intellectual development and thyroid function
of the off-spring. Acta Endocrinol(Copenh). 123: 311-316. |
| (44) |
Eisenstein Z, Weiss M, Katz Y, Bank H. 1992 Intellectual
capacity of subjects exposed to methimazole or propylthiouracil in utero.
Eur J Pediatr. 151: 558-559. |
| (45) |
Ramsay I, Kaur S. Krassas G. 1983 Thyrotoxicosis in pregnancy:
results of treatment by antithyroid drugs combined with T4. Clin Endocrinol(Oxf).
18: 73-85. |
| (46) |
Momotani N, Noh J, Ishikawa N, Ito K. 1994 Relationship
between silent thyroiditis and recurrent Graves' disease in the postpartum
period, J Clin Endocrinol Metab. 79: 285-289. |
| (47) |
Williams RH, Kay GA, Jandorf B. 1944 Thiouracil. Its absorption,
distribution, and excretion. J Clin Invest. 23: 613- 627. |
| (48) |
Kampmann JP, Johansen K, Hansen JM, Helweg J.
1980 Propylthiouracil in human milk, Lancet, 1: 736-38. |
| (49) |
Low LCK, Lang J, Alexander WD. 1979 Excretion of carbimazole and
propylthiouracil in breast milk. Lancet. 2: 1011. |
| (50) |
Tegler L, Lindstr6m B. 1980 Antithyriod drugs
in milk. Lancet. 2: 591. |
| (51) |
Johansen K, Andersen AN, Kampmann JP, Hansen JM, Mortensen HB.
1982 Excretion of methimazole in human milk. J Clin Pharmacol. 23: 339-341. |
| (52) |
Cooper DS, Bode HH, Nath B, Saxe V, Maloof F, Ridgway
EC. 1984 Methimazole pharmacology in man: studies using a newly developed
radioimmunoassay for methimazole, J Clin Endocrinol Metab. 58: 473-479. |
| (53) |
Azizi F, Khoshniat M, Bahrainian M, Hedayati M. 2000 Thyroid function
and Intellectual development of infants nursed by mothers taking methimazole.
J Clin Endocrinol Metab, 85: 3233-3238. |
| (54) |
Zaton A, Martinez A, DeGandaris JM. 1988 The
binding of thioureylene compounds to human serum albumin. Biochem Pharmacol.
37: 3127-3131. |
| (55) |
Lamberg BA, Ikonen E, 5sterlund K. et al. 1984 Antithyroid treatment
of maternal hyperthyroidism during lactation. Clin Endocrinol. 21: 81-87. |
| (56) |
Momotani N, Yamashita R, Yoshimoto M, Noh J, Ishikawa
N, Ito K. 1989 Recovery from fetal hypothyroidism: evidence for the
safety of breast feeding while taking propylthiouracil. Clin Endocrinol.
31: 591-595. |
| (57) |
Azizi F. 1996 Effect of methimazole treatment of maternal thyrotoxicosis
on thyroid function in breast feeding infants. J Pediatr. 128: 855-858. |
| (58) |
Momotani N, Yamashita R, Makino F, Noh J, Iahikawa
N, Ito K, Ito K. 2000 Thyroid function in wholly breast feeding infants
whose mothers take high doses of propylthiouracil. Clin Endocrinol. 53:
177-181. |